Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis

Payne, A. B., Watts, J. A., Mitchell, P. K., Dascomb, K., Irving, S. A., Klein, N. P., Grannis, S. J., Ong, T. C., Ball, S. W., DeSilva, M. B., Natarajan, K., Sheffield, T., Bride, D., Arndorfer, J., Naleway, A. L., Koppolu, P., Fireman, B., Zerbo, O., Timbol, J., … Link-Gelles, R. (2024). Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. The Lancet, 404(10462), 1547–1559. https://doi.org/10.1016/s0140-6736(24)01738-0
Authors:
Amanda B Payne
Janet A Watts
Patrick K Mitchell
Kristin Dascomb
Stephanie A Irving
Nicola P Klein
Shaun J Grannis
Toan C Ong
Sarah W Ball
Malini B DeSilva
Karthik Natarajan
Tamara Sheffield
Daniel Bride
Julie Arndorfer
Allison L Naleway
Padma Koppolu
Bruce Fireman
Ousseny Zerbo
Julius Timbol
Kristin Goddard
Brian E Dixon
William F Fadel
Colin Rogerson
Katie S Allen
Suchitra Rao
David Mayer
Michelle Barron
Sarah E Reese
Elizabeth A K Rowley
Morgan Najdowski
Allison Avrich Ciesla
Josephine Mak
Emily L Reeves
Omobosola O Akinsete
Charlene E McEvoy
Inih J Essien
Mark W Tenforde
Katherine E Fleming-Dutra
Ruth Link-Gelles
Affiliated Authors:
Karthik Natarajan
Columbia Affiliation:
Subjects:
Respiratory Syncytial Virus Infections (MeSH)
Hospitalization (MeSH)
Respiratory Syncytial Virus Vaccines (MeSH)
Emergency Service, Hospital (MeSH)
Vaccine Efficacy (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1016/s0140-6736(24)01738-0
PMID:
39426837
DOI:
10.1016/s0140-6736(24)01738-0
Journal:
Lancet
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: